Literature DB >> 3464164

Skeletal muscle adenosine, inosine and hypoxanthine release following ischaemic forearm exercise in myoadenylate deaminase deficiency and McArdle's disease.

S Sinkeler, E Joosten, R Wevers, R Binkhorst, L Oei.   

Abstract

Plasma adenosine, inosine and hypoxanthine concentrations were assayed in 7 controls, 5 MADD patients and 6 McArdle patients before and after ischaemic forearm exercise. The MADD patients showed a significantly lower increase in plasma inosine and hypoxanthine following exercise as compared to the controls. In the McArdle patients the increase in plasma inosine and hypoxanthine after exercise did not differ significantly from the control values. The plasma adenosine increase was very low in the three test groups and there were no significant differences.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3464164     DOI: 10.1007/978-1-4684-1248-2_80

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  5 in total

Review 1.  Myoadenylate deaminase deficiency.

Authors:  H H Goebel; A Bardosi
Journal:  Klin Wochenschr       Date:  1987-11-02

2.  Myoadenylate deaminase deficiency: successful symptomatic therapy by high dose oral administration of ribose.

Authors:  N Zöllner; S Reiter; M Gross; D Pongratz; C D Reimers; K Gerbitz; I Paetzke; T Deufel; G Hübner
Journal:  Klin Wochenschr       Date:  1986-12-15

Review 3.  Nucleoside salvage and resistance to antimetabolite anticancer agents.

Authors:  M Fox; J M Boyle; A R Kinsella
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

Review 4.  Resistance to chemotherapeutic antimetabolites: a function of salvage pathway involvement and cellular response to DNA damage.

Authors:  A R Kinsella; D Smith; M Pickard
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

Review 5.  Increased Adenine Nucleotide Degradation in Skeletal Muscle Atrophy.

Authors:  Spencer G Miller; Paul S Hafen; Jeffrey J Brault
Journal:  Int J Mol Sci       Date:  2019-12-21       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.